A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease

REFERENCES

• Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008; 31:439-77; PMID:18558863; http://dx.doi.org/10.1146/annurev.neuro.31.060407.125620
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728; PMID:18391177; http://dx.doi.org/10.1152/physrev.00007.2007
   PubMed Web of Science ®Google Scholar
• Biasini E, Turnbaugh JA, Unterberger U, Harris DA. Prion protein at the crossroads of physiology and disease. Trends Neurosci 2012; 35:92-103; PMID:22137337; http://dx.doi.org/10.1016/j.tins.2011.10.002
   PubMed Web of Science ®Google Scholar
• Linden R, Cordeiro Y, Lima LM. Allosteric function and dysfunction of the prion protein. Cell Mol Life Sci 2012; 69:1105-24; PMID:21984610; http://dx.doi.org/10.1007/s00018-011-0847-7
   PubMed Web of Science ®Google Scholar
• Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, Schurmann P, Windl O, Brose N, Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999; 19:8866-75; PMID:10516306
   PubMed Web of Science ®Google Scholar
• Mironov A, Jr, Latawiec D, Wille H, Bouzamondo-Bernstein E, Legname G, Williamson RA, Burton D, DeArmond SJ, Prusiner SB, Peters PJ. Cytosolic prion protein in neurons. J Neurosci 2003; 23:7183-93; PMID:12904479
   PubMed Web of Science ®Google Scholar
• Kannenberg K, Groschup MH, Sigel E. Cellular prion protein and GABAA receptors: no physical association? Neuroreport 1995; 7:77-80; PMID:8742421
   PubMed Web of Science ®Google Scholar
• Rangel A, Madronal N, Gruart i Masso A, Gavin R, Llorens F, Sumoy L, Torres JM, Delgado-Garcia JM, Del Rio JA. Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term potentiation in the hippocampus of prion mutant mice. PLoS One 2009; 4:e7592; PMID:19855845; http://dx.doi.org/10.1371/journal.pone.0007592
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Pietri M, Schneider B, Vidal C, Mutel V, Launay JM, Kellermann O. Modulation of serotonergic receptor signaling and cross-talk by prion protein. J Biol Chem 2005; 280:4592-601; PMID:15590675; http://dx.doi.org/10.1074/jbc.M406199200
   PubMed Web of Science ®Google Scholar
• Beraldo FH, Arantes CP, Santos TG, Queiroz NG, Young K, Rylett RJ, Markus RP, Prado MA, Martins VR. Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J Biol Chem 2010; 285:36542-50; PMID:20837487; http://dx.doi.org/10.1074/jbc.M110.157263
   PubMed Web of Science ®Google Scholar
• Carulla P, Bribian A, Rangel A, Gavin R, Ferrer I, Caelles C, Del Rio JA, Llorens F. Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding. Mol Biol Cell 2011; 22:3041-54; PMID:21757544; http://dx.doi.org/10.1091/mbc.E11-04-0321
   PubMed Web of Science ®Google Scholar
• Black SA, Stys PK, Zamponi GW, Tsutsui S. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity. Frontiers Cell Dev Biol 2014; 2:45; http://dx.doi.org/10.3389/fcell.2014.00045
   PubMedGoogle Scholar
• Rial D, Pamplona FA, Moreira EL, Moreira KM, Hipolide D, Rodrigues DI, Dombrowski PA, Da Cunha C, Agostinho P, Takahashi RN, Walz R, Cunha RA, Prediger RD. Cellular prion protein is present in dopaminergic neurons and modulates the dopaminergic system. Eur J Neurosci 2014; 40:2479-86; PMID:24766164; http://dx.doi.org/10.1111/ejn.12600
   PubMed Web of Science ®Google Scholar
• Gasperini L, Meneghetti E, Pastore B, Benetti F, Legname G. Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation. Antioxid Redox Signal 2015; 22:772-84; PMID:25490055; http://dx.doi.org/10.1089/ars.2014.6032
   PubMed Web of Science ®Google Scholar
• Beraldo FH, Arantes CP, Santos TG, Machado CF, Roffe M, Hajj GN, Lee KS, Magalhaes AC, Caetano FA, Mancini GL, et al. Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin gamma1 chain. Faseb J 2011; 25:265-79; PMID:20876210; http://dx.doi.org/10.1096/fj.10-161653
   PubMed Web of Science ®Google Scholar
• Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A, Wisniewski T, Koleske AJ, et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 2013; 79:887-902; PMID:24012003; http://dx.doi.org/10.1016/j.neuron.2013.06.036
   PubMed Web of Science ®Google Scholar
• Westaway D, Jhamandas JH. The P's and Q's of cellular PrP-Abeta interactions. Prion 2012; 6:359-63; PMID:22874673; http://dx.doi.org/10.4161/pri.20675
   PubMed Web of Science ®Google Scholar
• Beckman D, Santos LE, Americo TA, Ledo JH, de Mello FG, Linden R. Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice. J Biol Chem 2015; 290:20488-98; PMID:26152722; http://dx.doi.org/10.1074/jbc.M115.666156
   PubMed Web of Science ®Google Scholar
• Gadotti VM, Bonfield SP, Zamponi GW. Depressive-like behaviour of mice lacking cellular prion protein. Behavioural Brain Res 2012; 227:319-23; http://dx.doi.org/10.1016/j.bbr.2011.03.012
   PubMed Web of Science ®Google Scholar
• Nuvolone M, Aguzzi A. Altered Monoaminergic Systems and Depressive-like Behavior in Congenic Prion Protein Knock-out Mice. J Biol Chem 2015; 290:26350; PMID:26500295; http://dx.doi.org/10.1074/jbc.L115.689117
   PubMed Web of Science ®Google Scholar
• Nuvolone M, Kana V, Hutter G, Sakata D, Mortin-Toth SM, Russo G, Danska JS, Aguzzi A. SIRPalpha polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells. J Exp Med 2013; 210:2539-52; PMID:24145514; http://dx.doi.org/10.1084/jem.20131274
   PubMed Web of Science ®Google Scholar
• de Almeida CJ, Chiarini LB, da Silva JP, PM ES, Martins MA, Linden R. The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol 2005; 77:238-46; PMID:15539455; http://dx.doi.org/10.1189/jlb.1103531
   PubMed Web of Science ®Google Scholar
• Murata Y, Kotani T, Ohnishi H, Matozaki T. The CD47-SIRPalpha signalling system: its physiological roles and therapeutic application. J Biochem 2014; 155:335-44; PMID:24627525; http://dx.doi.org/10.1093/jb/mvu017
   PubMed Web of Science ®Google Scholar
• Beckman D, Santos LE, Americo TA, Ledo JH, de Mello FG, Linden R. Reply to Altered Monoaminergic Systems and Depressive-like Behavior in Congenic Prion Protein Knock-out Mice. J Biol Chem 2015; 290:26351; PMID:26500296; http://dx.doi.org/10.1074/jbc.L115.689232
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Murata T, Kusakari S, Hayashi Y, Takao K, Maruyama T, Ago Y, Koda K, Jin FJ, Okawa K, et al. Stress-evoked tyrosine phosphorylation of signal regulatory protein α regulates behavioral immobility in the forced swim test. J Neurosci 2010; 30:10472-83; PMID:20685990; http://dx.doi.org/10.1523/JNEUROSCI.0257-10.2010
   PubMed Web of Science ®Google Scholar
• Jin G, Tsuji K, Xing C, Yang YG, Wang X, Lo EH. CD47 gene knockout protects against transient focal cerebral ischemia in mice. Exp Neurol 2009; 217:165-70; PMID:19233173; http://dx.doi.org/10.1016/j.expneurol.2009.02.004
   PubMed Web of Science ®Google Scholar
• Wang L, Lu Y, Deng S, Zhang Y, Yang L, Guan Y, Matozaki T, Ohnishi H, Jiang H, Li H. SHPS-1 deficiency induces robust neuroprotection against experimental stroke by attenuating oxidative stress. J Neurochem 2012; 122:834-43; PMID:22671569; http://dx.doi.org/10.1111/j.1471-4159.2012.07818.x
   PubMed Web of Science ®Google Scholar
• Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL, Hermann DM. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol Dis 2005; 20:442-9; PMID:15893468; http://dx.doi.org/10.1016/j.nbd.2005.04.002
   PubMed Web of Science ®Google Scholar
• Mariante RM, Nobrega A, Martins RA, Areal RB, Bellio M, Linden R. Neuroimmunoendocrine regulation of the prion protein in neutrophils. J Biol Chem 2012; 287:35506-15; PMID:22910907; http://dx.doi.org/10.1074/jbc.M112.394924
   PubMed Web of Science ®Google Scholar
• Pinheiro LP, Linden R, Mariante RM. Activation and function of murine primary microglia in the absence of the prion protein. J Neuroimmunol 2015; 286:25-32; PMID:26298321; http://dx.doi.org/10.1016/j.jneuroim.2015.07.002
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Mutel V, Loric S, Tournois C, Launay JM, Kellermann O. Regulation by neurotransmitter receptors of serotonergic or catecholaminergic neuronal cell differentiation. J Biol Chem 2000; 275:9186-92; PMID:10734054; http://dx.doi.org/10.1074/jbc.275.13.9186
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289:1925-8; PMID:10988071; http://dx.doi.org/10.1126/science.289.5486.1925
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Schneider B, Pradines E, Pietri M, Ermonval M, Grassi J, Richards JG, Mutel V, Launay JM, Kellermann O. Cellular prion protein signaling in serotonergic neuronal cells. Annals New York Acad Sci 2007; 1096:106-19
   Google Scholar
• Mouillet-Richard S, Nishida N, Pradines E, Laude H, Schneider B, Feraudet C, Grassi J, Launay JM, Lehmann S, Kellermann O. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells. J Biol Chem 2008; 283:23782-90; PMID:18617522; http://dx.doi.org/10.1074/jbc.M802433200
   PubMed Web of Science ®Google Scholar
• Lee HG, Park SJ, Choi EK, Carp RI, Kim YS. Increased expression of prion protein is associated with changes in dopamine metabolism and MAO activity in PC12 cells. J Mol Neurosci 1999; 13:121-6; PMID:10691299; http://dx.doi.org/10.1385/JMN:13:1-2:121
   PubMed Web of Science ®Google Scholar
• Coitinho AS, Roesler R, Martins VR, Brentani RR, Izquierdo I. Cellular prion protein ablation impairs behavior as a function of age. Neuroreport 2003; 14:1375-9; PMID:12876477
   PubMed Web of Science ®Google Scholar
• Nazor KE, Seward T, Telling GC. Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression. Biochim Biophys Acta 2007; 1772:645-53; PMID:17531449; http://dx.doi.org/10.1016/j.bbadis.2007.04.004
   PubMed Web of Science ®Google Scholar
• Gasperini L, Legname G. Prion protein and aging. Frontiers Cell Dev Biol 2014; 2:44; http://dx.doi.org/10.3389/fcell.2014.00044
   PubMed Web of Science ®Google Scholar
• Massimino ML, Peggion C, Loro F, Stella R, Megighian A, Scorzeto M, Blaauw B, Toniolo L, Sorgato MC, Reggiani C, et al. Age-dependent neuromuscular impairment in prion protein knock-out mice. Muscle Nerve 2016; 53(2):269-79; PMID:25989742; http://dx.doi.org/10.1002/mus.24708
   PubMed Web of Science ®Google Scholar
• Cross AJ, Kimberlin RH, Crow TJ, Johnson JA, Walker CA. Neurotransmitter metabolites, enzymes and receptors in experimental scrapie. J Neurological Sci 1985; 70:231-41; http://dx.doi.org/10.1016/0022-510X(85)90090-5
   PubMed Web of Science ®Google Scholar
• Bassant MH, Picard M, Olichon D, Cathala F, Court L. Changes in the serotonergic, noradrenergic and dopaminergic levels in the brain of scrapie-infected rats. Brain Res 1986; 367:360-3; PMID:2421836; http://dx.doi.org/10.1016/0006-8993(86)91619-7
   PubMed Web of Science ®Google Scholar
• Ledoux JM. Effects on the serotoninergic system in sub-acute transmissible spongiform encephalopathies: current data, hypotheses, suggestions for experimentation. Med Hypotheses 2005; 64:910-8; PMID:15780484; http://dx.doi.org/10.1016/j.mehy.2004.11.020
   PubMed Web of Science ®Google Scholar
• Durand-Gorde JM, Bert J, Nieoullon A. Changes in tyrosine hydroxylase, glutamic acid decarboxylase and choline acetyltransferase after local microinoculation of scrapie agent into the nigrostriatal system of the golden hamster. Brain Res 1985; 341:243-51; PMID:2864098; http://dx.doi.org/10.1016/0006-8993(85)91063-7
   PubMed Web of Science ®Google Scholar
• Yun SW, Choi EK, Ju WK, Ahn MS, Carp RI, Wisniewski HM, Kim YS. Extensive degeneration of catecholaminergic neurons to scrapie agent 87V in the brains of IM mice. Mol Chem Neuropathol 1998; 34:121-32; PMID:10327412; http://dx.doi.org/10.1007/BF02815074
   PubMedGoogle Scholar
• Gunapala KM, Chang D, Hsu CT, Manaye K, Drenan RM, Switzer RC, Steele AD. Striatal pathology underlies prion infection-mediated hyperactivity in mice. Prion 2010; 4:302-15; PMID:20948312; http://dx.doi.org/10.4161/pri.4.4.13721
   PubMed Web of Science ®Google Scholar
• Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA, Strittmatter SM. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010; 30:6367-74; PMID:20445063; http://dx.doi.org/10.1523/JNEUROSCI.0395-10.2010
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, McIntyre RS, Alves GS, Fountoulakis KN, Carvalho AF. Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review. Curr Neuropharmacol 2015; 13:636-55; PMID:26467412; http://dx.doi.org/10.2174/1570159X13666150630175044
   PubMed Web of Science ®Google Scholar
• Thompson A, MacKay A, Rudge P, Lukic A, Porter MC, Lowe J, Collinge J, Mead S. Behavioral and psychiatric symptoms in prion disease. Am J Psychiatry 2014; 171:265-74; PMID:24585329; http://dx.doi.org/10.1176/appi.ajp.2013.12111460
   PubMed Web of Science ®Google Scholar
• Wanschitz J, Kloppel S, Jarius C, Birner P, Flicker H, Hainfellner JA, Gambetti P, Guentchev M, Budka H. Alteration of the serotonergic nervous system in fatal familial insomnia. Ann Neurol 2000; 48:788-91; PMID:11079543; http://dx.doi.org/10.1002/1531-8249(200011)48:5<788::AID-ANA13>3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Kloppel S, Pirker W, Brucke T, Kovacs GG, Almer G. Beta-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with Fatal Familial Insomnia. J Neural Transmission 2002; 109:1105-10; http://dx.doi.org/10.1007/s007020200093
   PubMed Web of Science ®Google Scholar
• Ragno M, Scarcella MG, Cacchio G, Capellari S, Di Marzio F, Parchi P, Trojano L. Striatal [123I] FP-CIT SPECT demonstrates dopaminergic deficit in a sporadic case of Creutzfeldt-Jakob disease. Acta neurologica Scandinavica 2009; 119:131-4; PMID:18638039; http://dx.doi.org/10.1111/j.1600-0404.2008.01075.x
   PubMed Web of Science ®Google Scholar
• Vital A, Fernagut PO, Canron MH, Joux J, Bezard E, Martin-Negrier ML, Vital C, Tison F. The nigrostriatal pathway in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 2009; 68:809-15; PMID:19535991; http://dx.doi.org/10.1097/NEN.0b013e3181abdae8
   PubMed Web of Science ®Google Scholar
• Benito-Leon J. Combined quinacrine and chlorpromazine therapy in fatal familial insomnia. Clin Neuropharmacol 2004; 27:201-3; PMID:15319710; http://dx.doi.org/10.1097/01.wnf.0000134853.36429.0e
   PubMed Web of Science ®Google Scholar
• Korth C, May BC, Cohen FE, Prusiner SB. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A 2001; 98:9836-41; PMID:11504948; http://dx.doi.org/10.1073/pnas.161274798
   PubMed Web of Science ®Google Scholar
• Trevitt CR, Collinge J. A systematic review of prion therapeutics in experimental models. Brain 2006; 129:2241-65; PMID:16816391; http://dx.doi.org/10.1093/brain/awl150
   PubMed Web of Science ®Google Scholar
• Lanctot KL, Herrmann N, Mazzotta P. Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci 2001; 13:5-21; PMID:11207325; http://dx.doi.org/10.1176/jnp.13.1.5
   PubMed Web of Science ®Google Scholar
• Rodriguez JJ, Noristani HN, Verkhratsky A. The serotonergic system in ageing and Alzheimer's disease. Prog Neurobiol 2012; 99:15-41; PMID:22766041; http://dx.doi.org/10.1016/j.pneurobio.2012.06.010
   PubMed Web of Science ®Google Scholar
• Lee HB, Lyketsos CG. Depression in Alzheimer's disease: heterogeneity and related issues. Biological Psychiatry 2003; 54:353-62; PMID:12893110; http://dx.doi.org/10.1016/S0006-3223(03)00543-2
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry 2003; 160:857-66; PMID:12727688; http://dx.doi.org/10.1176/appi.ajp.160.5.857
   PubMed Web of Science ®Google Scholar
• Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care. Neurosci Biobehavioral Rev 2013; 37:1363-79; http://dx.doi.org/10.1016/j.neubiorev.2013.05.008
   PubMed Web of Science ®Google Scholar
• Palmer AM, Wilcock GK, Esiri MM, Francis PT, Bowen DM. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res 1987; 401:231-8; PMID:2434191; http://dx.doi.org/10.1016/0006-8993(87)91408-9
   PubMed Web of Science ®Google Scholar
• Martorana A, Mori F, Esposito Z, Kusayanagi H, Monteleone F, Codeca C, Sancesario G, Bernardi G, Koch G. Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacol 2009; 34:2323-8; http://dx.doi.org/10.1038/npp.2009.60
   PubMed Web of Science ®Google Scholar
• Koch G, Di Lorenzo F, Bonni S, Giacobbe V, Bozzali M, Caltagirone C, Martorana A. Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients. Neuropsychopharmacol 2014; 39:2654-61; http://dx.doi.org/10.1038/npp.2014.119
   PubMed Web of Science ®Google Scholar
• Himeno E, Ohyagi Y, Ma L, Nakamura N, Miyoshi K, Sakae N, Motomura K, Soejima N, Yamasaki R, Hashimoto T, et al. Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation. Ann Neurol 2011; 69:248-56; PMID:21387370; http://dx.doi.org/10.1002/ana.22319
   PubMed Web of Science ®Google Scholar
• Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, Hayreh D, D'Angelo G, Benzinger T, Yoon H, et al. Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A 2011; 108:14968-73; PMID:21873225; http://dx.doi.org/10.1073/pnas.1107411108
   PubMed Web of Science ®Google Scholar
• Noristani HN, Verkhratsky A, Rodriguez JJ. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease. Aging Cell 2012; 11:810-22; PMID:22702392; http://dx.doi.org/10.1111/j.1474-9726.2012.00845.x
   PubMed Web of Science ®Google Scholar
• Perry VH, Cunningham C, Boche D. Atypical inflammation in the central nervous system in prion disease. Curr Opin Neurol 2002; 15:349-54; PMID:12045736; http://dx.doi.org/10.1097/00019052-200206000-00020
   PubMed Web of Science ®Google Scholar
• Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R, Williams A. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002; 40:232-9; PMID:12379910; http://dx.doi.org/10.1002/glia.10146
   PubMed Web of Science ®Google Scholar
• Perry VH. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 2004; 18:407-13; PMID:15265532; http://dx.doi.org/10.1016/j.bbi.2004.01.004
   PubMed Web of Science ®Google Scholar
• Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 2015; 16:358-72; PMID:25991443; http://dx.doi.org/10.1038/nrn3880
   PubMed Web of Science ®Google Scholar
• Sandu RE, Buga AM, Uzoni A, Petcu EB, Popa-Wagner A. Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology. Neural Regen Res 2015; 10:1349-55; PMID:26604877; http://dx.doi.org/10.4103/1673-5374.165208
   PubMed Web of Science ®Google Scholar
• Brown DR. Microglia and prion disease. Microscopy Res Technique 2001; 54:71-80; http://dx.doi.org/10.1002/jemt.1122
   PubMed Web of Science ®Google Scholar
• Rozemuller AJ, Jansen C, Carrano A, van Haastert ES, Hondius D, van der Vies SM, Hoozemans JJ. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration. Neurodegener Dis 2012; 10:301-4; PMID:22398730; http://dx.doi.org/10.1159/000335380
   PubMed Web of Science ®Google Scholar
• Wojtera M, Sobow T, Kloszewska I, Liberski PP, Brown DR, Sikorska B. Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature. Folia Neuropathol 2012; 50:74-84; PMID:22505366
   PubMedGoogle Scholar
• Llorens F, Lopez-Gonzalez I, Thune K, Carmona M, Zafar S, Andreoletti O, Zerr I, Ferrer I. Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease. Frontiers Aging Neurosci 2014; 6:198; http://dx.doi.org/10.3389/fnagi.2014.00198
   PubMed Web of Science ®Google Scholar
• Brown DR, Besinger A, Herms JW, Kretzschmar HA. Microglial expression of the prion protein. Neuroreport 1998; 9:1425-9; PMID:9631441; http://dx.doi.org/10.1097/00001756-199805110-00032
   PubMed Web of Science ®Google Scholar
• Amor S, Peferoen LA, Vogel DY, Breur M, van der Valk P, Baker D, van Noort JM. Inflammation in neurodegenerative diseases–an update. Immunol 2014; 142:151-66; http://dx.doi.org/10.1111/imm.12233
   PubMed Web of Science ®Google Scholar
• Nuvolone M, Sorce S, Schwarz P, Aguzzi A. Prion pathogenesis in the absence of NLRP3/ASC inflammasomes. PLoS One 2015; 10:e0117208; PMID:25671600; http://dx.doi.org/10.1371/journal.pone.0117208
   PubMed Web of Science ®Google Scholar
• Zhu C, Herrmann US, Li B, Abakumova I, Moos R, Schwarz P, Rushing EJ, Colonna M, Aguzzi A. Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains. Neurobiol Aging 2015; 36:1994-2003; PMID:25816748; http://dx.doi.org/10.1016/j.neurobiolaging.2015.02.019
   PubMed Web of Science ®Google Scholar
• Gomez-Nicola D, Fransen NL, Suzzi S, Perry VH. Regulation of microglial proliferation during chronic neurodegeneration. J Neurosci 2013; 33:2481-93; PMID:23392676; http://dx.doi.org/10.1523/JNEUROSCI.4440-12.2013
   PubMed Web of Science ®Google Scholar
• Grizenkova J, Akhtar S, Brandner S, Collinge J, Lloyd SE. Microglial Cx3cr1 knockout reduces prion disease incubation time in mice. BMC Neurosci 2014; 15:44; PMID:24655482; http://dx.doi.org/10.1186/1471-2202-15-44
   PubMed Web of Science ®Google Scholar
• Sorce S, Nuvolone M, Keller A, Falsig J, Varol A, Schwarz P, Bieri M, Budka H, Aguzzi A. The role of the NADPH oxidase NOX2 in prion pathogenesis. PLoS Pathog 2014; 10:e1004531; PMID:25502554; http://dx.doi.org/10.1371/journal.ppat.1004531
   PubMed Web of Science ®Google Scholar
• Kreisel T, Frank MG, Licht T, Reshef R, Ben-Menachem-Zidon O, Baratta MV, Maier SF, Yirmiya R. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry 2014; 19:699-709; PMID:24342992; http://dx.doi.org/10.1038/mp.2013.155
   PubMed Web of Science ®Google Scholar
• Yirmiya R, Rimmerman N, Reshef R. Depression as a Microglial Disease. Trends Neurosci 2015; 38:637-58; PMID:26442697; http://dx.doi.org/10.1016/j.tins.2015.08.001
   PubMed Web of Science ®Google Scholar
• Walker FR. A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacol 2013; 67:304-17; http://dx.doi.org/10.1016/j.neuropharm.2012.10.002
   PubMed Web of Science ®Google Scholar
• Hashioka S, Klegeris A, Monji A, Kato T, Sawada M, McGeer PL, Kanba S. Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol 2007; 206:33-42; PMID:17481608; http://dx.doi.org/10.1016/j.expneurol.2007.03.022
   PubMed Web of Science ®Google Scholar
• Ledo JH, Azevedo EP, Clarke JR, Ribeiro FC, Figueiredo CP, Foguel D, De Felice FG, Ferreira ST. Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice. Mol Psychiatry 2013; 18:1053-4; PMID:23183490; http://dx.doi.org/10.1038/mp.2012.168
   PubMed Web of Science ®Google Scholar
• Santos LE, Beckman D, Ferreira ST. Microglial dysfunction connects depression and Alzheimer's disease. Brain Behav Immun 2015; S0889-1591(15):30056-8
   Google Scholar
• Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and prion proteins. J Neurosci 1999; 19:928-39; PMID:9920656
   PubMed Web of Science ®Google Scholar
• Ding T, Zhou X, Kouadir M, Shi F, Yang Y, Liu J, Wang M, Yin X, Yang L, Zhao D. Cellular prion protein participates in the regulation of inflammatory response and apoptosis in BV2 microglia during infection with Mycobacterium bovis. J Mol Neurosci 2013; 51:118-26; PMID:23345082; http://dx.doi.org/10.1007/s12031-013-9962-2
   PubMed Web of Science ®Google Scholar
• Shi F, Yang L, Kouadir M, Yang Y, Ding T, Wang J, Zhou X, Yin X, Zhao D. Prion protein participates in the regulation of classical and alternative activation of BV2 microglia. J Neurochem 2012; 124(2):168-74; PMID:23061439; http://dx.doi.org/10.1111/jnc.12053
   PubMed Web of Science ®Google Scholar
• Maes M. Evidence for an immune response in major depression: a review and hypothesis. Progress Neuro-Psychopharmacology Biol Psychiatry 1995; 19:11-38
   Google Scholar
• Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001; 15:199-226; PMID:11566046; http://dx.doi.org/10.1006/brbi.2000.0597
   PubMed Web of Science ®Google Scholar
• Perry VH. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol 2010; 120:277-86; PMID:20644946; http://dx.doi.org/10.1007/s00401-010-0722-x
   PubMed Web of Science ®Google Scholar
• Cunningham C, Hennessy E. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research. Alzheimers Res Ther 2015; 7:33; PMID:25802557; http://dx.doi.org/10.1186/s13195-015-0117-2
   PubMed Web of Science ®Google Scholar
• Licursi PC, Merz PA, Merz GS, Carp RI. Scrapie-induced changes in the percentage of polymorphonuclear neutrophils in mouse peripheral blood. Infect Immun 1972; 6:370-6; PMID:4118048
   PubMed Web of Science ®Google Scholar
• Carp RI, Merz PA, Licursi PC, Merz GS. Replication of the factor in scrapie material that causes a decrease in polymorphonuclear neutrophils. J Infect Dis 1973; 128:256-8; PMID:4737373; http://dx.doi.org/10.1093/infdis/128.2.256
   PubMed Web of Science ®Google Scholar
• Miragliotta G, Fumarulo R, Fumarola D. Inhibition of neutrophil functions by scrapie prion protein: description of some inhibitory properties. Acta Virol 1990; 34:517-22; PMID:1983177
   PubMed Web of Science ®Google Scholar
• Scali C, Prosperi C, Bracco L, Piccini C, Baronti R, Ginestroni A, Sorbi S, Pepeu G, Casamenti F. Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease. Neurobiol Aging 2002; 23:523-30; PMID:12009501; http://dx.doi.org/10.1016/S0197-4580(01)00346-3
   PubMed Web of Science ®Google Scholar
• Licastro F, Morini MC, Davis LJ, Malpassi P, Cucinotta D, Parente R, Melotti C, Savorani G. Increased chemiluminescence response of neutrophils from the peripheral blood of patients with senile dementia of the Alzheimer's type. J Neuroimmunol 1994; 51:21-6; PMID:8157733; http://dx.doi.org/10.1016/0165-5728(94)90124-4
   PubMed Web of Science ®Google Scholar
• Davydova TV, Fomina VG, Voskresenskaya NI, Doronina OA. Phagocytic activity and state of bactericidal systems in polymorphonuclear leukocytes from patients with Alzheimer's disease. Bull Exp Biol Med 2003; 136:355-7; PMID:14714081; http://dx.doi.org/10.1023/B:BEBM.0000010950.53560.e2
   PubMed Web of Science ®Google Scholar
• Garlind A, Nilsson E, Palmblad J. Calcium ion transients in neutrophils from patients with sporadic Alzheimer's disease. Neurosci Lett 1998; 255:95-8; PMID:9835223; http://dx.doi.org/10.1016/S0304-3940(98)00716-2
   PubMed Web of Science ®Google Scholar
• Baik SH, Cha MY, Hyun YM, Cho H, Hamza B, Kim DK, Han SH, Choi H, Kim KH, Moon M, et al. Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Neurobiol Aging 2014; 35:1286-92; PMID:24485508; http://dx.doi.org/10.1016/j.neurobiolaging.2014.01.003
   PubMed Web of Science ®Google Scholar
• Achilli C, Ciana A, Minetti G. Amyloid-β (25-35) peptide induces the release of pro-matrix metalloprotease 9 (pro-MMP-9) from human neutrophils. Mol Cell Biochem 2014; 397:117-23; PMID:25087121; http://dx.doi.org/10.1007/s11010-014-2178-0
   PubMed Web of Science ®Google Scholar
• Gabbita SP, Johnson MF, Kobritz N, Eslami P, Poteshkina A, Varadarajan S, Turman J, Zemlan F, Harris-White ME. Oral TNFalpha Modulation Alters Neutrophil Infiltration, Improves Cognition and Diminishes Tau and Amyloid Pathology in the 3xTgAD Mouse Model. PLoS One 2015; 10:e0137305; PMID:26436670; http://dx.doi.org/10.1371/journal.pone.0137305
   PubMedGoogle Scholar
• Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, Turano E, Rossi B, Angiari S, Dusi S, et al. Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med 2015; 21:880-6; PMID:26214837; http://dx.doi.org/10.1038/nm.3913
   PubMed Web of Science ®Google Scholar
• Rummel C, Inoue W, Poole S, Luheshi GN. Leptin regulates leukocyte recruitment into the brain following systemic LPS-induced inflammation. Mol Psychiatry 2010; 15:523-34; PMID:19773811; http://dx.doi.org/10.1038/mp.2009.98
   PubMed Web of Science ®Google Scholar
• Aguilar-Valles A, Kim J, Jung S, Woodside B, Luheshi GN. Role of brain transmigrating neutrophils in depression-like behavior during systemic infection. Mol Psychiatry 2014; 19:599-606; PMID:24126927; http://dx.doi.org/10.1038/mp.2013.137
   PubMed Web of Science ®Google Scholar
• Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 2005; 25:9275-84; PMID:16207887; http://dx.doi.org/10.1523/JNEUROSCI.2614-05.2005
   PubMed Web of Science ®Google Scholar
• Joshi YB, Giannopoulos PF, Chu J, Pratico D. Modulation of lipopolysaccharide-induced memory insult, gamma-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase. Neurobiol Aging 2014; 35:1024-31; PMID:24332986; http://dx.doi.org/10.1016/j.neurobiolaging.2013.11.016
   PubMed Web of Science ®Google Scholar
• Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 2011; 12:723-38; PMID:22048062
   PubMed Web of Science ®Google Scholar
• Alkadhi KA. Chronic psychosocial stress exposes Alzheimer's disease phenotype in a novel at-risk model. Frontiers Biosci 2012; 4:214-29; http://dx.doi.org/10.2741/E371
   Google Scholar
• Machado A, Herrera AJ, de Pablos RM, Espinosa-Oliva AM, Sarmiento M, Ayala A, Venero JL, Santiago M, Villaran RF, Delgado-Cortes MJ, et al. Chronic stress as a risk factor for Alzheimer's disease. Rev Neurosci 2014; 25:785-804; PMID:25178904; http://dx.doi.org/10.1515/revneuro-2014-0035
   PubMed Web of Science ®Google Scholar
• Djamshidian A, Lees AJ. Can stress trigger Parkinson's disease? J Neurol Neurosurg Psychiatry 2014; 85:878-81; PMID:24259593; http://dx.doi.org/10.1136/jnnp-2013-305911
   PubMed Web of Science ®Google Scholar
• Greenberg MS, Tanev K, Marin MF, Pitman RK. Stress, PTSD, and dementia. Alzheimer's Dementia 2014; 10:S155-65; PMID:24924667; http://dx.doi.org/10.1016/j.jalz.2014.04.008
   PubMed Web of Science ®Google Scholar